• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Rapid and severe Covid-19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab.一名镰状细胞病患者出现快速进展且严重的新冠病毒肺炎并伴有严重急性胸部综合征，使用托珠单抗成功治疗。
Am J Hematol. 2020 Jul;95(7):876-878. doi: 10.1002/ajh.25833. Epub 2020 May 12.
2
Red blood cell exchange to avoid intubating a COVID-19 positive patient with sickle cell disease?进行红细胞置换以避免对患有镰状细胞病的新冠病毒阳性患者进行插管？
J Clin Apher. 2020 Aug;35(4):378-381. doi: 10.1002/jca.21809. Epub 2020 Jul 6.
3
Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience.托珠单抗联合糖皮质激素治疗重症和危重症 COVID-19 患者：单中心经验
Med Clin (Barc). 2020 Nov 13;155(9):410-411. doi: 10.1016/j.medcli.2020.07.001. Epub 2020 Jul 9.
4
First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab.首例多发性骨髓瘤合并 COVID-19 患者经托珠单抗治疗后成功缓解。
Blood Adv. 2020 Apr 14;4(7):1307-1310. doi: 10.1182/bloodadvances.2020001907.
5
COVID-19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patient.新冠病毒肺炎作为一名成年镰状细胞病患者急性胸综合征的病因
Am J Hematol. 2020 Jul;95(7):E154-E156. doi: 10.1002/ajh.25809. Epub 2020 Apr 21.
6
Vaso-occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID-19).2019新型冠状病毒病（COVID-19）所致镰状细胞病的血管闭塞性危机和急性胸综合征
Am J Hematol. 2020 Jun;95(6):725-726. doi: 10.1002/ajh.25821. Epub 2020 Apr 21.
7
Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Ischemic Stroke.严重急性呼吸综合征冠状病毒2感染与缺血性中风
Stroke. 2020 Jul;51(7):e124-e127. doi: 10.1161/STROKEAHA.120.030153. Epub 2020 May 12.
8
Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case-control study.脊髓损伤患者感染新型冠状病毒肺炎的临床特征与预后：一项病例对照研究
Spinal Cord Ser Cases. 2020 Aug 4;6(1):69. doi: 10.1038/s41394-020-0319-0.
9
COVID-19 pneumonia in a kidney transplant recipient successfully treated with tocilizumab and hydroxychloroquine.肾移植受者 COVID-19 肺炎成功接受托珠单抗和羟氯喹治疗。
Am J Transplant. 2020 Jul;20(7):1902-1906. doi: 10.1111/ajt.15935. Epub 2020 May 13.
10
Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review.以病例为基础的综述：使用司库奇尤单抗治疗的强直性脊柱炎患者的 2019 年冠状病毒病（COVID-19）。
Rheumatol Int. 2020 Oct;40(10):1707-1716. doi: 10.1007/s00296-020-04635-z. Epub 2020 Jun 26.

引用本文的文献

1
Impact of the SARS-CoV-2 infection in individuals with sickle cell disease: an integrative review.2019冠状病毒病感染对镰状细胞病患者的影响：一项综合综述。
Front Med (Lausanne). 2023 May 2;10:1144226. doi: 10.3389/fmed.2023.1144226. eCollection 2023.
2
COVID-19 outcomes in sickle cell disease and sickle cell trait.COVID-19 在镰状细胞病和镰状细胞特征中的结果。
Best Pract Res Clin Haematol. 2022 Sep;35(3):101382. doi: 10.1016/j.beha.2022.101382. Epub 2022 Sep 7.
3
Acute chest syndrome and COVID-19 in hydroxyurea naïve sickle cell disease patient in a low resource setting.资源匮乏地区未接受羟基脲治疗的镰状细胞病患者的急性胸部综合征与新型冠状病毒肺炎
EJHaem. 2022 Feb 7;3(2):507-512. doi: 10.1002/jha2.397. eCollection 2022 May.
4
Hyperhemolysis in a patient with sickle cell disease and recent SARS-CoV-2 infection, with complex auto- and alloantibody work-up, successfully treated with tocilizumab.镰状细胞病合并近期 SARS-CoV-2 感染患者出现严重溶血，经复杂的自身抗体和同种异体抗体检测，并用托珠单抗成功治疗。
Transfusion. 2022 Jul;62(7):1446-1451. doi: 10.1111/trf.16932. Epub 2022 May 30.
5
An Observational Study on Clinical and Epidemiological Profile of Pediatric Patients with Coronavirus Disease 2019 (COVID-19) Presenting With Comorbidities at RIMS, Ranchi.一项关于在兰契市RIMS医院就诊的合并症2019冠状病毒病（COVID-19）儿科患者临床和流行病学特征的观察性研究。
J Family Med Prim Care. 2022 Apr;11(4):1493-1496. doi: 10.4103/jfmpc.jfmpc_1447_21. Epub 2022 Mar 18.
6
Coronavirus disease 2019 (COVID-19) in special groups: A single-center experience in sickle cell disease patients in Saudi Arabia.2019冠状病毒病（COVID-19）在特殊群体中的情况：沙特阿拉伯镰状细胞病患者的单中心经验
J Family Community Med. 2022 Jan-Apr;29(1):71-78. doi: 10.4103/jfcm.jfcm_376_21. Epub 2022 Jan 19.
7
Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature.镰状细胞病和镰状细胞性状患者感染新型冠状病毒肺炎的临床结局：文献的批判性评价
Blood Rev. 2022 May;53:100911. doi: 10.1016/j.blre.2021.100911. Epub 2021 Nov 20.
8
COVID-19 and Hemoglobinopathies: A Systematic Review of Clinical Presentations, Investigations, and Outcomes.新型冠状病毒肺炎与血红蛋白病：临床表现、检查及预后的系统评价
Front Med (Lausanne). 2021 Oct 13;8:757510. doi: 10.3389/fmed.2021.757510. eCollection 2021.
9
Potential Implications of a Type 1 Interferon Gene Signature on COVID-19 Severity and Chronic Inflammation in Sickle Cell Disease.1型干扰素基因特征对镰状细胞病中COVID-19严重程度和慢性炎症的潜在影响。
Front Med (Lausanne). 2021 Jul 22;8:679030. doi: 10.3389/fmed.2021.679030. eCollection 2021.
10
Current evidence for directed and supportive investigational therapies against COVID-19.针对新型冠状病毒肺炎（COVID-19）的定向和支持性研究性治疗的当前证据。
Afr J Thorac Crit Care Med. 2020 Apr 30;26(2). doi: 10.7196/AJTCCM.2020.v26i2.072. eCollection 2020.

本文引用的文献

1
COVID-19: consider cytokine storm syndromes and immunosuppression.2019冠状病毒病：考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
2
Extracorporeal Life Support for Severe Acute Chest Syndrome in Adult Sickle Cell Disease: A Preliminary Report.体外生命支持治疗成人镰状细胞病严重急性胸部综合征：初步报告。
Crit Care Med. 2019 Mar;47(3):e263-e265. doi: 10.1097/CCM.0000000000003628.
3
Inflammation in sickle cell disease.镰状细胞病中的炎症
Clin Hemorheol Microcirc. 2018;68(2-3):263-299. doi: 10.3233/CH-189012.
4
Severe pandemic H1N1 and seasonal influenza in children and young adults with sickle cell disease.儿童和青年镰状细胞病患者中严重的大流行性 H1N1 流感和季节性流感。
Blood. 2010 Nov 4;116(18):3431-4. doi: 10.1182/blood-2010-05-282194. Epub 2010 Jul 23.
5
Burden of influenza-related hospitalizations among children with sickle cell disease.镰状细胞病患儿与流感相关的住院负担。
Pediatrics. 2010 Feb;125(2):234-43. doi: 10.1542/peds.2009-1465. Epub 2010 Jan 25.
6
Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group.镰状细胞病急性胸综合征的病因及转归。国家急性胸综合征研究小组。
N Engl J Med. 2000 Jun 22;342(25):1855-65. doi: 10.1056/NEJM200006223422502.
7
Serum interleukin-6 levels in the steady state of sickle cell disease.镰状细胞病稳定期的血清白细胞介素-6水平
J Interferon Cytokine Res. 1995 Dec;15(12):1061-4. doi: 10.1089/jir.1995.15.1061.

Rapid and severe Covid-19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab.

作者信息

De Luna Gonzalo, Habibi Anoosha, Deux Jean-François, Colard Martin, Pham Hung d'Alexandry d'Orengiani Anne-Laure, Schlemmer Frédéric, Joher Nizar, Kassasseya Christian, Pawlotsky Jean Michel, Ourghanlian Clément, Michel Marc, Mekontso-Dessap Armand, Bartolucci Pablo

机构信息

Sickle Cell Referral Center, Department of Internal Medicine, Henri-Mondor University Hospital- UPEC, AP-HP, Créteil, France.

Department of Radiology, Henri Mondor Hospital/AP-HP, Créteil, France.

出版信息

Am J Hematol. 2020 Jul;95(7):876-878. doi: 10.1002/ajh.25833. Epub 2020 May 12.

DOI:10.1002/ajh.25833
PMID:32282956
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7262334/
Abstract
摘要